Annual EBITDA
-$56.38M$92.11M+62.03%
Summary
- Current Value
- As of today, TXG annual EBITDA is -$56.38M, up +62.03% on
- Historical Performance
- TXG annual EBITDA is up +56.87% over the past 3 years, up +14.97% over the past 5 years
- All-Time High Comparison
- TXG annual EBITDA is currently -305.14% below its historical high of -$13.92M set on
- 3-Year Low Comparison
- TXG annual EBITDA is +64.37% above its 3-year low of -$158.25M reached on
- Sector Comparison
- TXG annual EBITDA is higher than 26.90% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$56.38M | +62.0% | +56.9% | +15.0% | -300.7% | |
| Quarterly EBITDA | -$13.29M | -1340.0% | +74.2% | -233.0% | – | |
| TTM EBITDA | -$43.14M | +60.5% | +69.5% | -80.5% | – | |
| Price | $93.50 | +659.5% | +130.9% | -35.0% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $642.82M | +5.3% | +24.5% | +115.1% | +804.3% | |
| Annual EPS | -$0.35 | +77.0% | +76.1% | +93.5% | -77.4% | |
| -$110.89M | +42.3% | +32.3% | -30.0% | -503.5% | ||
| Annual Net Income | -$43.54M | +76.2% | +73.8% | +92.0% | -132.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$56.38M | at high | |
| 5Y | -$24.66M | -128.6% | |
| All | -$13.92M | -305.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$158.25M | +64.4% | |
| 5Y | -$158.25M | +64.4% | |
| All | -$158.25M | +64.4% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$56.38M | +62.0% | |
| -$148.49M | +6.2% | |
| -$158.25M | -21.1% | |
| -$130.72M | -430.1% | |
| -$24.66M | +62.8% |
| Year | Value | Change |
|---|---|---|
| -$66.30M | -201.3% | |
| -$22.01M | -58.1% | |
| -$13.92M | +1.1% | |
| -$14.07M | - |
FAQ
- What is the current annual EBITDA of TXG?
- As of today, TXG annual EBITDA is -$56.38M
- What is 1-year change in TXG annual EBITDA?
- TXG annual EBITDA is up +62.03% year-over-year
- What is 3-year change in TXG annual EBITDA?
- TXG annual EBITDA is up +56.87% over the past 3 years
- How far is TXG annual EBITDA from its all-time high?
- TXG annual EBITDA is currently -305.14% below its historical high of -$13.92M set on December 31, 2018
- How does TXG annual EBITDA rank versus sector peers?
- TXG annual EBITDA is higher than 26.90% of companies in Healthcare sector
- When is TXG next annual earnings release?
- As of today, the next annual earnings release for TXG has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$13.29M$6.20M-87.49%
Summary
- Current Value
- As of today, TXG quarterly EBITDA is -$13.29M, down -87.49% on
- Historical Performance
- TXG quarterly EBITDA is down -1339.98% year-over-year, up +74.18% over the past 3 years
- All-Time High Comparison
- TXG quarterly EBITDA is currently -534.49% below its historical high of $3.06M set on
- 3-Year Low Comparison
- TXG quarterly EBITDA is +72.25% above its 3-year low of -$47.90M reached on
- Sector Comparison
- TXG quarterly EBITDA is higher than 27.95% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$13.29M | -87.5% | -1340.0% | +74.2% | -233.0% | |
| Annual EBITDA | -$56.38M | – | +62.0% | +56.9% | +15.0% | |
| TTM EBITDA | -$43.14M | -40.2% | +60.5% | +69.5% | -80.5% | |
| Price | $93.50 | +139.7% | +659.5% | +130.9% | -35.0% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $151.04M | +0.1% | -12.7% | +2.9% | +30.4% | |
| Quarterly EPS | -$0.14 | -31.4% | -149.8% | +74.2% | -37.2% | |
| -$22.96M | -34.7% | -117.1% | +63.8% | -105.4% | ||
| Quarterly Net Income | -$17.93M | -33.1% | -151.9% | +71.3% | -62.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.77M | -379.5% | |
| 3Y | -$923.00K | -1340.0% | |
| 5Y | -$923.00K | -1340.0% | |
| All | $3.06M | -534.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$19.99M | N/A | +33.5% |
| 3Y | -$47.90M | +72.3% | |
| 5Y | -$54.67M | +75.7% | |
| All | -$73.90M | +82.0% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of TXG?
- As of today, TXG quarterly EBITDA is -$13.29M
- What is TXG quarterly EBITDA most recent change?
- TXG quarterly EBITDA was down -87.49% on June 30, 2026
- What is 1-year change in TXG quarterly EBITDA?
- TXG quarterly EBITDA is down -1339.98% year-over-year
- How far is TXG quarterly EBITDA from its all-time high?
- TXG quarterly EBITDA is currently -534.49% below its historical high of $3.06M set on December 31, 2020
- How does TXG quarterly EBITDA rank versus sector peers?
- TXG quarterly EBITDA is higher than 27.95% of companies in Healthcare sector
- When is TXG next earnings release?
- The next earnings release for TXG is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$43.14M$12.37M-40.19%
Summary
- Current Value
- As of today, TXG TTM EBITDA is -$43.14M, down -40.19% on
- Historical Performance
- TXG TTM EBITDA is up +60.52% year-over-year, up +69.48% over the past 3 years
- All-Time High Comparison
- TXG TTM EBITDA is currently -229.49% below its historical high of -$13.09M set on
- 3-Year Low Comparison
- TXG TTM EBITDA is +73.89% above its 3-year low of -$165.26M reached on
- Sector Comparison
- TXG TTM EBITDA is higher than 31.65% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$43.14M | -40.2% | +60.5% | +69.5% | -80.5% | |
| Annual EBITDA | -$56.38M | – | +62.0% | +56.9% | +15.0% | |
| Quarterly EBITDA | -$13.29M | -87.5% | -1340.0% | +74.2% | -233.0% | |
| Price | $93.50 | +139.7% | +659.5% | +130.9% | -35.0% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $616.91M | -3.4% | -4.3% | +8.5% | +52.1% | |
| TTM EPS | -$0.59 | -238.2% | +16.0% | +60.4% | +87.5% | |
| -$87.12M | -16.6% | +42.0% | +51.2% | -82.1% | ||
| TTM Net Income | -$75.13M | -231.6% | +11.2% | +56.4% | +85.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$30.78M | -40.2% | |
| 3Y | -$30.78M | -40.2% | |
| 5Y | -$13.09M | N/A | -229.5% |
| All | -$13.09M | -229.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$98.54M | N/A | +56.2% |
| 3Y | -$165.26M | +73.9% | |
| 5Y | -$165.26M | +73.9% | |
| All | -$165.26M | +73.9% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of TXG?
- As of today, TXG TTM EBITDA is -$43.14M
- What is TXG TTM EBITDA most recent change?
- TXG TTM EBITDA was down -40.19% on June 30, 2026
- What is 1-year change in TXG TTM EBITDA?
- TXG TTM EBITDA is up +60.52% year-over-year
- How far is TXG TTM EBITDA from its all-time high?
- TXG TTM EBITDA is currently -229.49% below its historical high of -$13.09M set on September 30, 2021
- How does TXG TTM EBITDA rank versus sector peers?
- TXG TTM EBITDA is higher than 31.65% of companies in Healthcare sector
- When is TXG next earnings release?
- The next earnings release for TXG is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000162828026007822/0001628280-26-007822-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg